Cardiopulmonary Exercise Testing Provides Additional Prognostic Information in Cystic Fibrosis

被引:104
|
作者
Hebestreit, Helge [1 ]
Hulzebos, Erik H. J. [2 ]
Schneiderman, Jane E. [3 ]
Karila, Chantal [4 ]
Boas, Steven R. [5 ]
Kriemler, Susi [6 ]
Dwyer, Tiffany [7 ,8 ,9 ]
Sahlberg, Margareta [10 ]
Urquhart, Don S. [11 ]
Lands, Larry C. [12 ]
Ratjen, Felix [3 ]
Takken, Tim [2 ]
Varanistkaya, Liobou [1 ]
Ruecker, Viktoria [13 ]
Hebestreit, Alexandra [1 ]
Usemann, Jakob [14 ]
Radtke, Thomas [6 ]
Junge, Sibylle [15 ]
Smaczny, Christine [16 ]
Rand, Sarah [17 ,18 ]
Dawson, Charlotte [17 ]
机构
[1] Univ Childrens Hosp, Wurzburg, Germany
[2] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Child Dev & Exercise Ctr, Utrecht, Netherlands
[3] Hosp Sick Children, Div Resp Med, Dept Pediat, Toronto, ON, Canada
[4] Univ Paris V Descartes, Hop Necker Enfants Malad, Ctr Ressources & Competences Mucoviscidose, Serv Pneumol & Allergol Pediat, Paris, France
[5] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[6] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland
[7] Univ Sydney, Fac Hlth Sci, Discipline Physiotherapy, Sydney, NSW, Australia
[8] Univ Sydney, Sydney Med Sch, Cent Clin Sch, Sydney, NSW, Australia
[9] Royal Prince Alfred Hosp, Dept Resp & Sleep Med, Sydney, NSW, Australia
[10] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Pediat, Gothenburg, Sweden
[11] Royal Hosp Sick Children, Dept Paediat Resp & Sleep Med, Edinburgh, Midlothian, Scotland
[12] McGill Univ, Hlth Ctr, Montreal Childrens Hosp, Montreal, PQ, Canada
[13] Inst Clin Epidemiol & Biometry, Wurzburg, Germany
[14] Univ Childrens Hosp Basel, Basel, Switzerland
[15] Hannover Med Sch, Clin Pediat Pneumol & Neonatol, Hannover, Germany
[16] Goethe Univ, Univ Hosp Frankfurt Main, Med Clin 1, Pneumol & Allergol, Frankfurt, Germany
[17] Great Ormond St Hosp Sick Children, London, England
[18] UCL, Inst Child Hlth, London, England
关键词
cystic fibrosis; prognosis; peak oxygen uptake; exercise testing; lung transplantation; BODY-MASS INDEX; CFTR GENOTYPE; LUNG-FUNCTION; MORTALITY; PREDICTION; SURVIVAL; PERCENTILES; ADOLESCENTS; CHILDREN;
D O I
10.1164/rccm.201806-1110OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: The prognostic value of cardiopulmonary exercise testing (CPET) for survival in cystic fibrosis (CF) in the context of current clinical management, when controlling for other known prognostic factors, is unclear. Objectives: To determine the prognostic value of CPET-derived measures beyond peak oxygen uptake ((V) over dot(O2)peak) following rigorous adjustment for other predictors. Methods: Data from 10 CF centers in Australia, Europe, and North America were collected retrospectively. A total of 510 patients completed a cycle CPET between January 2000 and December 2007, of which 433 fulfilled the criteria for a maximal effort. Time to death/lung transplantation was analyzed using Cox proportional hazards regression. In addition, phenotyping using hierarchical Ward clustering was performed to characterize high-risk subgroups. Measurements and Main Results: Cox regression showed, even after adjustment for sex, FEV1% predicted, body mass index (z-score), age at CPET, Pseudomonas aeruginosa status, and CF-related diabetes as covariates in the model, that (V) over dot(O2)peak in % predicted (hazard ratio [HR], 0.964; 95% confidence interval [CI], 0.944-0.986), peak work rate (% predicted; HR, 0.969; 95% CI, 0.951-0.988), ventilatory equivalent for oxygen (HR, 1.085; 95% CI, 1.041-1.132), and carbon dioxide (HR, 1.060; 95% CI, 1.007-1.115) (all P, 0.05) were significant predictors of death or lung transplantation at 10-year follow-up. Phenotyping revealed that CPET-derived measures were important for clustering. We identified a high-risk cluster characterized by poor lung function, nutritional status, and exercise capacity. Conclusions: CPET provides additional prognostic information to established predictors of death/lung transplantation in CF. High-risk patients may especially benefit from regular monitoring of exercise capacity and exercise counseling.
引用
收藏
页码:987 / 995
页数:9
相关论文
共 50 条
  • [31] SERIAL TROPONIN TESTING PROVIDES ADDITIONAL PROGNOSTIC INFORMATION IN PATIENTS HOSPITALIZED WITH COVID-19
    Lobo, Ronstan
    De Michieli, Laura
    Spears, Grant M.
    Jaffe, Allan S.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 1303 - 1303
  • [32] Exercise testing in cystic fibrosis: Who and why?
    Urquhart, D. S.
    Saynor, Z. L.
    [J]. PAEDIATRIC RESPIRATORY REVIEWS, 2018, 27 : 28 - 32
  • [33] Exercise testing and prognosis in adult cystic fibrosis
    Moorcroft, AJ
    Dodd, ME
    Webb, AK
    [J]. THORAX, 1997, 52 (03) : 291 - 293
  • [34] Exercise testing in cystic fibrosis: why (and how)?
    Urquhart, D. S.
    [J]. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2011, 104 : S6 - S14
  • [35] Cardiopulmonary responses to maximal aerobic exercise in patients with cystic fibrosis
    Williams, Craig A.
    Wedgwood, Kyle C. A.
    Mohammadi, Hossein
    Prouse, Katie
    Tomlinson, Owen W.
    Tsaneva-Atanasova, Krasimira
    [J]. PLOS ONE, 2019, 14 (02):
  • [36] STRUCTURE FUNCTION RELATIONSHIPS IN EARLY CYSTIC FIBROSIS LUNG DISEASE: UTILITY OF CARDIOPULMONARY EXERCISE TESTING INDICES
    Middleton, A.
    Bayfield, K. J.
    Weinheimer, O.
    Boyton, C.
    Fitzpatrick, R.
    Kennedy, B.
    Blaxland, A.
    Jayasuriya, G.
    Caplain, N.
    Wielpuetz, M. O.
    Robinson, T. E.
    Gustafsson, P.
    Fitzgerald, D.
    Selvadurai, H.
    Robinson, P. D.
    [J]. PEDIATRIC PULMONOLOGY, 2020, 55 : S211 - S211
  • [37] Cardiopulmonary Exercise Testing in Combined Pulmonary Fibrosis and Emphysema
    Westhoff, Michael
    Litterst, Patric
    Ewert, Ralf
    [J]. RESPIRATION, 2021, 100 (05) : 395 - 403
  • [38] FEASIBILITY OF CARDIOPULMONARY EXERCISE TESTING IN IDIOPATHIC PULMONARY FIBROSIS
    Wollerton, R. L.
    Tomlinson, O. W.
    Knight, B. A.
    Duckworth, A.
    Spiers, A.
    Williams, C. A.
    Gibbons, M.
    Scotton, C. J.
    [J]. THORAX, 2018, 73 : A225 - A226
  • [39] Prognostic significance of cardiopulmonary exercise testing in hypertrophic cardiomyopathy
    Zegkos, T.
    Parcharidou, D.
    Efthimiadis, G.
    Didagelos, M.
    Ntelios, D.
    Hatzimiltiadis, S.
    Ziakas, A.
    Karvounis, H.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 364 - 364
  • [40] Prognostic value of cardiopulmonary exercise testing in cardiac amyloidosis
    Nicol, Martin
    Deney, Antoine
    Lairez, Olivier
    Vergaro, Giuseppe
    Emdin, Michele
    Carecci, Alessandro
    Inamo, Jocelyn
    Montfort, Astrid
    Neviere, Remi
    Damy, Thibaud
    Harel, Stephanie
    Royer, Bruno
    Baudet, Mathilde
    Cohen-Solal, Alain
    Arnulf, Bertrand
    Logeart, Damien
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (02) : 231 - 239